Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05512143 · ClinicalTrials.gov registry record · NA
TMS for PTSD and Blood Pressure
A NA study of Hypertension and Post Traumatic Stress Disorder, sponsored by Lifespan.
- Active
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05512143: Active NA study of Hypertension and Post Traumatic Stress Disorder, sponsored by Lifespan.
NCT05512143 is a NA study of Hypertension and Post Traumatic Stress Disorder that is active but no longer recruiting, run by Lifespan. The registered enrollment target is 30 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05512143, a NA study of Hypertension and Post Traumatic Stress Disorder, is active but no longer recruiting, sponsored by Lifespan.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
In this randomized clinical trial, we will test the short and longer term effects of repetitive transcranial magnetic stimulation (TMS) on blood pressure among reproductive aged female participants with elevated symptoms of post-traumatic stress disorder and hypertension.
Primary Outcome
Change in 24-hour blood pressure before and after TMS intervention
Conditions Studied
Interventions
- DEVICE Transcranial magnetic stimulation
Study Locations (1)
Rhode Island
- Lifespan Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2024-02-15 |
| Est. Completion | 2028-01-31 |
| Phase | NA |
What the registry record for NCT05512143 still lists
NCT05512143 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Transcranial magnetic stimulation is the first listed.
NCT05512143 reports a single indexed study location in Rhode Island.
Frequently Asked Questions
What is clinical trial NCT05512143 about?
NCT05512143 is a clinical study titled "TMS for PTSD and Blood Pressure". In this randomized clinical trial, we will test the short and longer term effects of repetitive transcranial magnetic stimulation (TMS) on blood pressure among reproductive aged female participants with elevated symptoms of post-traumatic stress disorder and hypertension.
What is the current status of trial NCT05512143?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-02-15. Estimated completion is 2028-01-31.
What conditions does trial NCT05512143 study?
This clinical trial studies the following conditions: Hypertension, Post Traumatic Stress Disorder.
What interventions are being tested in trial NCT05512143?
The interventions under investigation include: Transcranial magnetic stimulation (DEVICE).
Who is sponsoring clinical trial NCT05512143?
This trial is sponsored by Lifespan, which has 18 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05512143 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05512143's enrollment target sits among peer trials
30 408th of 470 higher than 54 of 470 other Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Early Time-Restricted Eating in Older Adults With Hypertension
RECRUITING · NA
-
Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI